AOD-9604 5mg

AOD-9604 — 5 mg lyophilised research peptide for in vitro assay development and peptide pharmacology. Research use only; not for human use.

£30.00

Description

AOD-9604 is a research peptide derived from the C-terminal region of human growth hormone, used in controlled in-vitro studies of peptide pharmacology, receptor-adjacent signalling, and assay development under non-clinical laboratory conditions.

AOD-9604 — 5 mg | Research Use Only

This listing provides a 5 mg vial of AOD-9604 for cell-based and biochemical model systems. Investigations focus on molecular mechanisms and assay readouts only.
For laboratory research only. Not for human use.

Key features

 

 

  • hGH-derived research peptide for in-vitro signalling/SAR investigations.

  • Supplied as a lyophilised solid for stability and straightforward storage.

  • Unit size: 5 mg per vial.

  • Each batch released after stringent internal quality checks.

 

 

Specifications for AOD-9604

  • Product name: AOD-9604

  • Synonyms: hGH fragment analogue; C-terminal hGH peptide

  • Class: Peptide fragment/analogue (research use)

  • Form: Lyophilised powder

  • Appearance: White to off-white solid

  • Note: Salt/counter-ion and hydration state may vary. Refer to the vial label for lot-specific details.

Handling & storage of AOD-9604

  1. Storage (dry): Keep vials at 2–8 °C, protected from light and moisture.

  2. Reconstitution: For step-by-step guidance, see our internal guide:
    Reconstituting & Storage.

  3. After reconstitution: Store at 2–8 °C, protect from light, use aliquots to reduce handling, and avoid repeated temperature cycling.

  4. Compatibility: Use only within research protocols that follow your lab’s SOPs and local regulations.

Important: Free empty 10 ml vial included (AOD-9604 is gel-prone)

Every AOD-9604 order includes a free empty 10 ml vial. AOD-9604 can be gel-prone at higher concentrations. For best laboratory handling, we recommend preparing a minimum total volume of 5 ml after reconstitution to reduce the chance of gelling.

  1. Step 1: Reconstitute AOD-9604 in the original peptide vial with 2 ml of diluent.

  2. Step 2: Transfer the solution to the included empty 10 ml vial.

  3. Step 3: Add additional diluent to reach a minimum total volume of 5 ml.

Note: If AOD-9604 is reconstituted into too small a volume, it may gel, particularly with high-purity material.

Looking for complementary materials? See the guide above and related GH-axis research peptides such as
HGH-Frag (176–191) 5 mg,
CJC-1295 (No DAC) 5 mg, and
Ipamorelin 5 mg.

About AOD-9604 in research

Researchers use AOD-9604 to examine peptide fragment analogues in model systems, profile downstream second-messenger responses, and compare structure–activity relationships alongside other GH-axis reagents. All studies occur exclusively in controlled, non-clinical in-vitro environments.

Synthesis & quality

Manufactured via controlled, validated peptide-synthesis processes to deliver high purity and lot-to-lot consistency. Each batch undergoes identity, purity, and appearance checks before release.

Legal & safety

XL Peptides supplies materials strictly for laboratory research. Products are not medications, foods, supplements, or cosmetics; not for human or veterinary use. By purchasing, you confirm you are a qualified researcher and will handle the material in line with your institution’s policies and applicable laws.

FAQs about AOD-9604

Why is an empty 10 ml vial included?
AOD-9604 can be gel-prone at higher concentrations. The empty 10 ml vial supports preparation at a higher total volume (minimum 5 ml) for improved handling in research workflows.

Where can I find reconstitution guidance?
See our step-by-step internal guide:
Reconstituting & Storage.

Is this product for human use?
No. This material is for research only and is not intended for human consumption or clinical applications.

External resources for researchers

Related research peptides

Disclaimer

Used solely for in vitro experiments and cannot be:

  • Used in clinical trials involving humans

  • Administered to humans as part of an experiment or investigation

  • Supplied to another party for human investigational use

XL Peptides works with various third-party laboratories to provide testing reports for all its manufactured products.